The reality,
say leading stem cell researchers, is that every disease and disorder needs its own special formula, including just the right promoter chemicals given at just the right dose, and just the right kind of stem cells introduced at just the right stage.
Not exact matches
Enabling scientists to grow the
stem cells artificially from pluripotent
stem cells could also
lead to the development of personalized blood therapies,
researchers say.
The reason,
say researchers: the hormone stimulates production of more oligodendrocyte
stem cells,
leading to more oligodendrocytes and therefore more myelin.
That debate is in full force this week as
researchers led by Kui Liu at the University of Gothenburg in Sweden
say they have ruled out the tantalising possibility that ovarian
stem cells exist.
«The induced pluripotent
stem cells we used in this study proved to be extremely useful in disease modelling, and they could offer an excellent platform for drug discovery and testing new therapeutic targets for Alzheimer's disease in the future,»
says Early Stage
Researcher Minna Oksanen, the
lead author of the study.
These lines are available for
researchers funded by the US National Institutes of Health (NIH) and the California Institute for Regenerative Medicine (CIRM) in San Francisco,
says Jeremy Crook, a
stem cell biologist at the University of Melbourne, Australia, who
led the team that made the lines.
Lead researcher Dr Gordana Vunjak - Novakovic
said: «The availability of personalised bone grafts engineered from the patient's own
stem cells would revolutionise the way we currently treat these defects.»
The Boston Globe «CAMBRIDGE — The
stem cell wars are not over,
say leading researchers at Harvard and other universities who believe that the cloning of...